- This event has passed.
Applying chemical biology to expand the range of actionable targets for nuclear medicine applications
September 9, 2022 @ 3:00 pm - 4:00 pm
Dr. Michael Evans
Associate Professor in Residence, Department of Radiology and Biomedical Imaging, Pharmaceutical Chemistry, UCSF
Michael Evans, PhD, is an Associate Professor in Residence in the UCSF Department of Radiology and Biomedical Imaging. He is a chemical biologist with an interest in biomarker discovery with proteomics, nuclear medicine, theranostics, and molecular imaging. Dr. Evans earned a BA in Chemistry from St. Mary’s College of Maryland and he obtained his PhD in Organic Chemistry from The Scripps Research Institute (CA) under the supervision of Professor Benjamin Cravatt. This was followed by a postdoctoral fellowship in Molecular Imaging from the Memorial Sloan Kettering Cancer Center in New York under the supervision of Professors Charles Sawyers and Jason Lewis. In 2013, Dr. Evans accepted a faculty position at UCSF. Dr. Evans has published over 80 peer-reviewed articles, 40 meeting abstracts, and is a co-inventor on 8 patents pending or issued. Dr. Evans also is the principal investigator or co-PI on several human trials focused on new strategies for imaging tumors. He is a scientific co-founder and previously served on the scientific advisory board of ORIC Pharmaceuticals, Inc., and is a scientific co-founder of Suba Therapeutics, Inc. Dr. Evans has been recognized with numerous honors, including a Young Investigator Award from the Prostate Cancer Foundation, a K99/R00 Pathway to Independence Award from the National Cancer Institute, a Research Scholar Award from the American Cancer Society, and he was a 2020 inductee to the Council of Distinguished Investigators by the Academy of Radiology and Biomedical Imaging Research.
Webinar ID: 986 1256 7590